NCT00382590
- Conditions
- Acute Myelogenous Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
- Locations
-
- UT MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Acute Myelogenous Leukemia
Explore clinical trials studying Acute Myelogenous Leukemia. Study availability and eligibility vary by location and protocol.
154 public trials
8 recruiting studies
Acute Myelogenous Leukemia trial results
Completed
Quality of Life of Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)
NCT00459524
- Conditions
- Acute Myelogenous Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
- Locations
-
- U.T.M.D. Anderson Cancer Center Houston, Texas, United States
NCT00038831
- Conditions
- Acute Myelogenous Leukemia, Bone Marrow Diseases, Chronic Disease, +20 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
NCT00569010
- Conditions
- Acute Myelogenous Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
- Locations
-
- U.T.M.D. Anderson Cancer Center Houston, Texas, United States
NCT00326170
- Conditions
- Acute Myelogenous Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
- Locations
-
- The University of Texas M.D. Anderson Cancer Center Houston, Texas, United States
NCT00719836
- Conditions
- Acute Myelogenous Leukemia, Bone Marrow Diseases, Chronic Disease, +19 more
- Locations
-
- The University of Chicago Hospitals Chicago, Illinois, United States
- MD Anderson Cancer Center Houston, Texas, United States
- Fred Hutchinson Cancer Center Seattle, Washington, United States
NCT00270881
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Bone Marrow Diseases, +24 more
- Locations
-
- Keio University School of Medicine Tokyo, Japan
NCT00981240
- Conditions
- Acute Myelogenous Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- Sanofi-Aventis Investigational Site Number 840003 Atlanta, Georgia, United States
- Sanofi-Aventis Investigational Site Number 840002 New York, United States
- Sanofi-Aventis Investigational Site Number 840001 Houston, Texas, United States
NCT00144677
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Bone Marrow Diseases, +28 more
- Locations
-
- Dana-Farber Cancer Center Boston, Massachusetts, United States
NCT00088231
- Conditions
- Acute Myelogenous Leukemia, Agnogenic Myeloid Metaplasia, Blast Crisis, +19 more
- Locations
-
- M.D. Anderson Cancer Center Houston, Texas, United States